Dermatology and Ophthalmology Kume Clinic

Sakai 593-8324

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Atopic Hand and Foot Dermatitis, Eczema

Studies at this site

• A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Running, not enrolling
• A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis — Running, not enrolling